(Q37940543)

25 August 2017

1 reference

title

Cardiovascular and metabolic safety profiles of the fluoroquinolones (English)

1 reference

25 August 2017

Alfredo Vannacci

6

0 references

Gian Maria Rossolini

object named as

Gian Maria Rossolini

4

0 references

Alessandro Bartoloni

3

object named as

Alessandro Bartoloni

1 reference

25 August 2017

Alessandra Pugi

1

1 reference

25 August 2017

Loreta Longo

2

1 reference

25 August 2017

Alessandro Mugelli

5

1 reference

25 August 2017

Francesco Lapi

7

1 reference

25 August 2017

language of work or name

English

0 references

publication date

30 September 2011

1 reference

Expert Opinion on Drug Safety

25 August 2017

published in

1 reference

25 August 2017

volume

11

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

53-69

1 reference

The crisis in antibiotic resistance

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Safety concerns with fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Clinical use of the fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Assessment of pharmacokinetic-pharmacodynamic target attainment of gemifloxacin against Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Antimicrobial safety: focus on fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Safety profile of the fluoroquinolones: focus on levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Glucose homeostasis abnormalities associated with use of gatifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Gatifloxacin produces both hypoglycemia and hyperglycemia: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Severe dysglycemia with the fluoroquinolones: a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Dysglycaemias and fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Adverse drug reactions: definitions, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Anecdotes that provide definitive evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Avoidance of ingestion of anti-inflammatory drugs in dyspepsia is confounding variable

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Drug Points: tachycardia associated with moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Levofloxacin induced polymorphic ventricular tachycardia with normal QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Ciprofloxacin-induced acquired long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Ciprofloxacin- and hypocalcemia-induced torsade de pointes triggered by hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Ciprofloxacin-induced Q-T interval prolongation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Glyburide-ciprofloxacin interaction with resistant hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Drug points: Diabetes inspidus induced by ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Refractory hypoglycemia from ciprofloxacin and glyburide interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Fatal hypoglycemia associated with levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Hypoglycemia-induced anoxic brain injury possibly associated with levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Hypoglycemia and levofloxacin: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Levofloxacin-induced hypoglycemia: a rare but life-threatening side effect of a widely used antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Hypoglycemia associated with the use of levofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Post-marketing surveillance of the safety of levofloxacin in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Exploring the effect of transient exposure on the risk of acute events by means of time-window designs: an application to fluoroquinolone antibacterials and arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Adverse events associated with prolonged antibiotic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Outpatient gatifloxacin therapy and dysglycemia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

The effects of levofloxacin on ECG parameters and late potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effects of three fluoroquinolones on QT interval in healthy adults after single doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effects of three fluoroquinolones on QT analysis after standard treatment courses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Electrocardiographic QTc changes due to moxifloxacin infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Etiology of diarrhea in young children and patterns of antibiotic resistance in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Acute renal failure probably induced by prulifloxacin in an elderly woman : a first case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Safety considerations of fluoroquinolones in the elderly: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Increase in insulin release from rat pancreatic islets by quinolone antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Gatifloxacin affects GLUT1 gene expression and disturbs glucose homeostasis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Glucose transporter gene expression: regulation of transcription and mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Clinical practice. Vertebral osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Prosthetic-joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.624512

10.1517/14740338.2011.624512

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference